Gout, hyperuricemy and cardiovascular diseases. Approaches to pharmacotherapy
Approaches to conducting patients with gout or hyperuricemy were considered, the necessity of screening and correction of purine, lipid and hydrocarbon metabolism was indicated, as well as the measures directed to prevention of cardiovascular complications.
Saved in:
| Main Authors: | V. V. Tsurko, T. E. Morozova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2021-06-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/565 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01) -
Pharmacotherapy of gout – modern approaches and prospects
by: P. A. Lebedev, et al.
Published: (2021-08-01) -
Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease
by: S. I. Smiyan, et al.
Published: (2015-12-01) -
Features of diet in patients with cardiometabolic diseases with gout and hyperuricemia: A review
by: Margarita A. Gromova, et al.
Published: (2025-01-01) -
GOUT OUTCOMES. A REVIEW OF LITERATURE. PART 1. GOUT: EPIDEMIOLOGY, RISK FACTORS, COURSE OF THE DISEASE WITH THE DEVELOPMENT OF CHRONIC TOPHUS FORM
by: Igor Sergeyevich Denisov, et al.
Published: (2013-12-01)